Mean (SD) demographic characteristics of study patients
| Characteristics | Placebo | Fluticasone |
|---|---|---|
| FEV1=forced expiratory volume in 1 second; VC=vital capacity; Kco=carbon monoxide transfer coefficient. | ||
| Male/female | 9/1 | 13/1 |
| Age | 65.5 (7) | 65.3 (6) |
| FEV1 (l) | 1.46 (0.4) | 1.44 (0.4) |
| FEV1 (% predicted) | 49.7 (13.4) | 50.3 (12.7) |
| VC (litres) | 3.5 (0.9) | 3.7 (0.7) |
| FEV1/VC (%) | 53.6 (9.9) | 49.9 (14.4) |
| FEV25–75 | 0.54 (0.2) | 0.52 (0.3) |
| Reversibility (%) | 7.6 (5.8) | 6.8 (5.8) |
| Kco (% predicted) | 55.0 (4.5) | 52.0 (5.1) |
| Pack years | 63.3 (36) | 57.6 (36) |
| Cigarettes/day | 27.1 (17.0) | 25.4 (19.0) |